Anavex Life Sciences remains one of the few non-amyloid Alzheimer's drug developers. Find out why I rate AVXL stock as a Hold ...

Eisai has retreated from the optimistic view of sales growth for Alzheimer's disease drug Leqembi it held earlier this year as uptake remains sluggish. In its six-month financial report for the ...

Experts are encouraged that the effects are similar to those seen with recent trials of amyloid-lowering therapies, including Leqembi and Eisai and Biogen’s predecessor drug Aduhelm (aducanumab ...

Since the launch of The Crossword in 1942, The Times has captivated solvers by providing engaging word and logic games. In 2014, we introduced The Mini Crossword — followed by Spelling Bee ...

Navdeep Kaur allegedly confessed to the thefts and is no longer with the U.S. Post ...

THE Drug Control and Enforcement Authority (DCEA) has destroyed 614.12 kilogrammes of illegal drugs which were seized and kept as evidence. Aretas Lyimo, the commissioner general, told journalists at ...

Stewart-Haas' sad demise belies its legacy of unlikely success (October 31, 2024, 7:00 PM ET) ...

Readers respond to Paige Williams’s report on bears in Lake Tahoe, Alice Gregory’s Profile of the philosopher L. A. Paul, and Jennifer Wilson’s piece about heartbreak remedies.

Stock gave a 3 year return of 75.64% as compared to Nifty Smallcap 100 which gave a return of 83.77%. (as of last trading session) Stock Returns vs Nifty Pharma Stock generated 75.64% return as ...

Mangalam Drugs and Organics Ltd., incorporated in the year 1972, is a Small Cap company (having a market cap of Rs 184.18 Crore) operating in Pharmaceuticals sector. Mangalam Drugs and Organics Ltd.

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...